Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Asset Resilience Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has an Asset Resilience Ratio of 0.31% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how financially flexible is Hunan Dajiaweikang Pharmaceutical Indust to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Asset Resilience Ratio has changed over time. See 301126 equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hunan Dajiaweikang Pharmaceutical Indust (301126) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥19.82 Million | 0.31% |
| Total Liquid Assets | CN¥19.82 Million | 0.31% |
Asset Resilience Insights
- Limited Liquidity: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd maintains only 0.31% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3 |
Pharmaceutical Retailers | 0.38% |
|
Oriola-KD Oyj B
HE:OKDBV |
Pharmaceutical Retailers | 14.13% |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3 |
Pharmaceutical Retailers | 2.05% |
|
Empreendimentos Pague Menos S.A
SA:PGMN3 |
Pharmaceutical Retailers | 0.00% |
|
High Tide Inc
V:HITI |
Pharmaceutical Retailers | 0.03% |
|
Yifeng Pharmacy
SHG:603939 |
Pharmaceutical Retailers | 19.16% |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233 |
Pharmaceutical Retailers | 0.80% |
|
Laobaixing Pharmacy
SHG:603883 |
Pharmaceutical Retailers | 0.01% |
Annual Asset Resilience Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.16% | CN¥9.82 Million ≈ $1.44 Million |
CN¥6.34 Billion ≈ $927.29 Million |
-2.39pp |
| 2022-12-31 | 2.54% | CN¥100.00 Million ≈ $14.63 Million |
CN¥3.93 Billion ≈ $575.29 Million |
-- |
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more